Previous numerous studies have reported that PTPRC was densely associated with the anti-TNF therapy response in RA patients, meaning that PTPRC could effectively predict and guide personalized medicine in RA therapy (78–80). The gene discussed is PTPRC; the disease is rheumatoid arthritis.